BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-13.7%
5Y CAGR+26.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-13.7%/yr
vs +49.5%/yr prior
5Y CAGR
+26.4%/yr
Recent deceleration
Acceleration
-63.2pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.93M | -28.4% |
| 2024 | $8.29M | -22.0% |
| 2023 | $10.64M | +15.4% |
| 2022 | $9.22M | +46.3% |
| 2021 | $6.30M | +242.5% |
| 2020 | $1.84M | +42.4% |
| 2019 | $1.29M | -30.0% |
| 2018 | $1.85M | +69.2% |
| 2017 | $1.09M | -12.0% |
| 2016 | $1.24M | - |